Jeffrey Scott Cole - 07 Feb 2024 Form 3 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role: Chief Operating Officer
Signature: /s/ Matthew K. Szot, Attorney-in-fact
Issuer symbol: CVKD
Transactions as of: 07 Feb 2024
Net transactions value: $0
Form type: 3
Filing time: 03 Apr 2024, 17:19:31 UTC
Next filing: 03 Apr 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CVKD	Stock Options							07 Feb 2024	Common Stock	50,000	$0.6400	Direct	F1
holding	CVKD	Stock Options							07 Feb 2024	Common Stock	150,000	$0.9400	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of options to purchase 50,000 shares of common stock granted on July 11, 2022, which vested fully on August 1, 2023.
F2	Consists of options to purchase 150,000 shares of common stock granted on January 18, 2024, which vest 1/4 on February 1, 2025 and thereafter pro rata on a monthly basis over three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Remarks:

Exhibit List - Exhibit 24- Power of Attorney (Jeffrey S. Cole)